Cytomx TherapeuticsCTMX
13F holders, Q2 2024 (June 30)74holders −14
13new positions
27sold out
3famous investors
$1.22avg. 13F price*
At the end of Q2 2024, 74 institutions reported holding Cytomx Therapeutics Inc. (CTMX) in their 13F filings, down 14 from Q1 2024. 13 opened new positions and 27 sold out. The largest holders were Tang Capital Management LLC ($9.5M), Janus Henderson Group PLC ($7.7M) and BVF Inc. ($6.4M). 3 famous investors held it, including Jim Simons / Peter Brown (0.0% of Renaissance Technologies's portfolio), Israel Englander (0.0% of Millennium Management's portfolio) and Ken Griffin (0.0% of Citadel Advisors's portfolio).
- Company
- Cytomx Therapeutics Inc.
- CUSIP
- 23284F105
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q1 2024 → Q2 2024
| Institutions | Total Value | |
|---|---|---|
| New Positions | 13 | $10.2M |
| Exits | 27 | $16.3M |
All 13F filers, Q1 2024 → Q2 2024: 17,645,239 shares bought and 11,509,106 shares sold, net +6,136,133 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 74 holders
| Tang Capital Management LLC | 0.97% | Add +20.8% | 7,791,936 | $9.5M |
| Janus Henderson Group PLC | 0.00% | New | 6,301,983 | $7.7M |
| BVF Inc. | 0.18% | Reduce -20.7% | 5,228,461 | $6.4M |
| Vanguard Group Inc. | 0.00% | Add +0.7% | 4,892,302 | $6.0M |
| Adage Capital Partners Gp, L.L.C. | 0.01% | Add +50.0% | 3,000,000 | $3.7M |
| Acadian Asset Management LLC | 0.01% | Add +1.4% | 2,728,569 | $3.3M |
| Millennium Management | 0.00% | Add +174.8% | 1,845,403 | $2.3M |
| Laurion Capital Management LP | 0.06% | Add +99.7% | 1,526,387 | $1.9M |
| Jacobs Levy Equity Management, Inc. | 0.01% | Add +184.5% | 1,507,717 | $1.8M |
| Schonfeld Strategic Advisors LLC | 0.01% | Add +7.9% | 1,375,290 | $1.7M |
| Assenagon Asset Management S.A. | 0.00% | Add +206.1% | 1,238,499 | $1.5M |
| RTW Investments, LP | 0.02% | New | 1,200,002 | $1.5M |
| Renaissance Technologies | 0.00% | Reduce -4.0% | 1,183,022 | $1.4M |
| Congress Park Capital LLC | 0.57% | Add +393.3% | 1,153,220 | $1.4M |
| Superstring Capital Management LP | 1.77% | Add +69.5% | 1,151,518 | $1.4M |
| BlackRock Inc. | 0.00% | Add +0.7% | 1,139,029 | $1.4M |
| Geode Capital Management, LLC | 0.00% | Add +2.1% | 769,499 | $939K |
| Two Sigma Investments, LP | 0.00% | Add +160.8% | 661,947 | $808K |
| ADAR1 Capital Management, LLC | 0.14% | Add +269.1% | 572,170 | $698K |
| Citadel Advisors | 0.00% | Add +1245.0% | 494,643 | $603K |
| Sei Investments Co. | 0.00% | New | 382,723 | $467K |
| Bridgeway Capital Management, LLC | 0.01% | Reduce -16.7% | 369,124 | $450K |
| Ghost Tree Capital, LLC | 0.13% | Reduce -50.0% | 300,000 | $366K |
| State Street Corp. | 0.00% | Reduce -1.4% | 263,643 | $322K |
| Formidable Asset Management, LLC | 0.05% | Reduce -10.4% | 258,001 | $315K |
| Tidal Investments LLC | 0.00% | Reduce -10.4% | 258,001 | $315K |
| Connor, Clark & Lunn Investment Management Ltd. | 0.00% | Reduce -16.5% | 254,220 | $310K |
| FMR LLC | 0.00% | Add +32.4% | 242,358 | $296K |
| Bank of New York Mellon Corp | 0.00% | Add +0.0% | 241,982 | $295K |
| Gsa Capital Partners LLP | 0.02% | Add +54.2% | 229,093 | $279K |
| Candriam S.C.A. | 0.00% | New | 210,027 | $256K |
| Squarepoint Ops LLC | 0.00% | Reduce -5.4% | 198,840 | $243K |
| Morgan Stanley | 0.00% | Reduce -78.0% | 188,486 | $230K |
| Two Sigma Advisers, LP | 0.00% | Add +7.9% | 158,400 | $193K |
| Northern Trust Corp. | 0.00% | Reduce -2.3% | 131,027 | $160K |
| Goldman Sachs Group Inc. | 0.00% | Reduce -62.8% | 109,302 | $133K |
| Creative Planning | 0.00% | New | 107,000 | $131K |
| Cubist Systematic Strategies, LLC | 0.00% | Add +96.6% | 82,054 | $100K |
| Cornercap Investment Counsel Inc. | 0.02% | Reduce -0.9% | 80,591 | $98K |
| Jane Street Group, LLC | 0.00% | Reduce -56.6% | 79,701 | $97K |
| UBS Group AG | 0.00% | Add +243.4% | 70,368 | $86K |
| Forefront Analytics, LLC | 0.04% | Add +206.7% | 64,065 | $78K |
| XTX Topco Ltd | 0.01% | Add +382.6% | 60,586 | $74K |
| Qube Research & Technologies Ltd | 0.00% | Reduce -59.0% | 54,608 | $67K |
| Susquehanna Fundamental Investments, LLC | 0.00% | Reduce -4.1% | 54,422 | $66K |
| Commonwealth Equity Services, LLC | 0.00% | Add +1.9% | 54,243 | $66K |
| Private Advisor Group, LLC | 0.00% | Reduce -24.6% | 52,179 | $64K |
| Stifel Financial Corp. | 0.00% | New | 47,100 | $57K |
| Russell Investments Group, Ltd. | 0.00% | Add +0.0% | 42,814 | $52K |
| Prudential Financial Inc. | 0.00% | Add +14.4% | 36,500 | $45K |
| LPL Financial LLC | 0.00% | Reduce -60.7% | 36,315 | $44K |
| Susquehanna International Group, LLP | 0.00% | Reduce -97.2% | 25,919 | $32K |
| Charles Schwab Investment Management Inc. | 0.00% | No change | 24,817 | $30K |
| Invesco Ltd. | 0.00% | New | 23,094 | $28K |
| Lazard Asset Management LLC | 0.00% | Add +1417.3% | 18,481 | $22K |
| WestHill Financial Advisors, Inc. | 0.01% | No change | 17,082 | $21K |
| Tower Research Capital LLC (TRC) | 0.00% | New | 17,039 | $21K |
| Group One Trading LLC | 0.00% | Add +2563.1% | 16,964 | $21K |
| LMR Partners LLP | 0.00% | Reduce -17.5% | 15,046 | $18K |
| Nierenberg Investment Management Company, LLC | 0.01% | New | 12,555 | $15K |
| IPG Investment Advisors LLC | 0.00% | No change | 12,500 | $15K |
| Ikarian Capital, LLC | 0.00% | New | 8,924 | $11K |
| Bank of America Corp. | 0.00% | Reduce -92.6% | 5,744 | $7K |
| Simplex Trading, LLC | 0.00% | Reduce -35.8% | 3,891 | $4K |
| Whittier Trust Co. | 0.00% | Reduce -66.7% | 2,200 | $3K |
| Rhumbline Advisers | 0.00% | No change | 1,291 | $2K |
| Osaic Holdings, Inc. | 0.00% | New | 900 | $1K |
| Bollard Group LLC | 0.00% | No change | 712 | $1K |
| JPMorgan Chase & Co. | 0.00% | No change | 281 | $343 |
| Raleigh Capital Management Inc. | 0.00% | No change | 250 | $305 |
| Federated Hermes, Inc. | 0.00% | Reduce -97.3% | 117 | $143 |
| BNP Paribas Financial Markets | 0.00% | No change | 78 | $95 |
| Innealta Capital, LLC | 0.00% | New | 2 | $2 |
| Royal Bank of Canada | 0.00% | New | 248 | $0 |
"% of holder's portfolio" is CTMX's weight in each manager's 13F, not the share of Cytomx Therapeutics Inc. the manager owns.